Trials / Conditions / Lymphoma, Large-Cell
Lymphoma, Large-Cell
6 registered clinical trials studyying Lymphoma, Large-Cell.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma NCT01118845 | SymBio Pharmaceuticals | Phase 2 |
| Completed | Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL NCT00546793 | Gilead Sciences | Phase 1 / Phase 2 |
| Withdrawn | MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Ly NCT00298467 | Bristol-Myers Squibb | Phase 2 |
| Completed | Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT NCT00256490 | Eric Turcotte | N/A |
| Completed | Large Cell Lymphoma Pilot Study III NCT00187070 | St. Jude Children's Research Hospital | N/A |
| Completed | A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malign NCT00051597 | Seagen Inc. | Phase 1 / Phase 2 |